FGFR4 and cancer: FGFR4 activation has been associated with cancer progression and resistance to different types of anti-cancer therapy and preclinical studies have shown that FGFR4 knockdown or pharmacologic inhibition can inhibit tumor growth and metastasis both in vitro and in vivo (see58 for review).